Meta-analysis of rare and adverse event data

Sutton, Alexander J, Cooper, Nicola J, Lambert, Paul C, Jones, David R, Abrams, Keith R, Sweeting, Michael J·2002·Expert Review of Pharmacoeconomics & Outcomes Research

Cited by (141)

Items 101–141 of 141

  1. Clopidogrel compared with other antiplatelet agents for secondary prevention of vascular events in adults undergoing percutaneous coronary intervention: clinical and cost-effectiveness analyses.
    Shao‐Yuan Chen, Elizabeth Russell, S Banerjee, Brian Hutton, A Brown, Kiyoshi Asakawa, Lynda McGahan, Mary Ann Clark, M Severn, Jafna L. Cox et al. · 2012 · Europe PMC (PubMed Central)
  2. A comparison of confidence distribution approaches for rare event meta‐analysis
    Brinley N. Zabriskie, Chris Corcoran, Pralay Senchaudhuri · 2021 · Statistics in Medicine
  3. Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding
    Ask Daffy Kvisselgaard, Signe Amalie Wolthers, Anne Juul Wikkelsø, Lars Broksø Holst, Bergitte Drivenes, Arash Afshari · 2026 · Cochrane Database of Systematic Reviews
  4. Assessing the quality of meta-analyses in systematic reviews in pharmaceutical research in Iran by 2016: A systematic review.
    Alireza Amanollahi, Maziar Moradi‐Lakeh, Farhad Shokraneh, Yousef Bashiri, Leily Mahmudi · 2020 · PubMed Central
  5. Evidence Synthesis in Harm Assessment of Medicines Using the Example of Rosiglitazone and Myocardial Infarction
    Charlotte Rietbergen, Gudrun Stefansdottir, Hubert G. M. Leufkens, Mirjam J. Knol, Marie L. De Bruin, Irene G. Klugkist · 2018 · Frontiers in Medicine
  6. Fibrinogen concentrate in severely bleeding patients for acquired hypofibrinogenaemia
    Anne Juul Wikkelsø, Arash Afshari, Ann Merete Møller · 2010 · Cochrane Database of Systematic Reviews
  7. Central venous catheter (CVC) removal for adult patients with candidaemia
    Susanne Janum, Arash Afshari · 2014 · Cochrane Database of Systematic Reviews
  8. Temporal evolution of publication bias in drug safety assessment: A case study on association between osteonecrosis of the jaw and bisphosphonates
    Nimetullah Aksoy, Guillaume Grenet, Maelys Granal, Marine Auffret, François Gueyffier, A. Lajoinie, Jean‐Christophe Lega, Emmanuel Massy, A. Gougeon · 2025 · Joint Bone Spine
  9. Les Arcanes décryptées de l'analyse médico économique à l'usage du décideur
    R Launois · 2008 · Journal de gestion et d économie médicales
  10. Synthèse des données probantes et évaluation des technologies médicales
    R Launois · 2009 · Santé Décision Management
  11. Concepts, Methods, and Practical Considerations of Meta-Analysis in Drug Development
    Zhenming Shun, Gao Lei, Qianying Liu, Wei Zheng, Hui Quan, Simon Hitier · 2016 · Statistics in Biopharmaceutical Research
  12. Meta-analysis of Rare Diseases in Occupational Epidemiology.
    DM McElvenny · 2017 · LSHTM Research Online (London School of Hygiene and Tropical Medicine)
  13. Meta-analysis for Rare Events in Clinical Trials
    Ding‐Geng Chen, Karl E. Peace · 2018 · ICSA book series in statistics
  14. Assessing the quality of meta-analyses in systematic reviews in pharmaceutical research in Iran by 2016: A systematic review
    Alireza Amanollahi, Maziar Moradi‐Lakeh, Farhad Shokraneh, Yousef Bashiri, Leily Mahmudi · 2020 · Medical Journal of the Islamic Republic of Iran
  15. Innovations in Post-Marketing Safety Research
    Gudrun Stefansdottir · 2012 · Utrecht University Repository (Utrecht University)
  16. Flow-regulated versus differential pressure-regulated shunt valves for adult patients with normal pressure hydrocephalus
    Morten Ziebell, Jørn Wetterslev, Magnus Tisell, Christian Nyfeldt Gluud, Marianne Juhler · 2012 · Cochrane Database of Systematic Reviews
  17. An exploration of evidence synthesis methods for adverse events
    Fiona C Warren · 2010 · Figshare
  18. Interventions to increase physical activity for people with congenital heart disease
    Susanne Hwiid Klausen, Roselien Buys, Lars L. Andersen, Asle Hirth, Brian W. McCrindle, Hanne Wacher Kjærgaard, Jørn Wetterslev · 2014 · Cochrane Database of Systematic Reviews · Retracted
  19. Response to letter by Messeri et al
    Tullio Palmerini, Giuseppe Biondi‐Zoccai, Diego Della Riva, Andrea Mariani, Gregg W. Stone · 2013 · American Heart Journal
  20. Hierarchical Random-Effect Meta-Analysis of Binary Events Investigating the Relation between Treatment Effect and Underlying Risk
    Jingjing Yan · 2014 · OhioLink ETD Center (Ohio Library and Information Network)
  21. Bayesian Meta-analysis of Rare Events with Non-ignorable Missing Data
    Xinyue Qi, Shouhao Zhou, Yucai Wang, Michael L. Wang, Chan Shen · 2021 · arXiv (Cornell University)
  22. Measuring the Impact of Zero-Cases Studies in Evidence Synthesis Practice Using the Harms Index and Benefits Index (Hi-Bi)
    Chang Xu, Luis Furuya‐Kanamori, Lifeng Lin, Liliane Zorzela, Tianqi Yu, Sunita Vohra · 2022 · BMC Medical Research Methodology
  23. ความอยดมสขของวยรน: การวเคราะหอภมานโมเดลสมการเชงโครงสราง
    นัฏฐิกา เจริญตะคุ, สุรศักดิ์ เก้าเอี้ยน · 2019
  24. Analysis of rare events in healthcare intervention using department of defense data: intravenous immune globulin therapy for bullous pemphigoid
    Onur Başer, Hüseyin Yüce, Gabriela Samayoa · 2025 · BMC Medical Research Methodology
  25. Meta-Analysis of Open vs Closed Surgery of Mandibular Condyle Fractures
    Marcy L. Nussbaum · 2006 · VCU Scholars Compass (Virginia Commonwealth University)
  26. Additional file 1 of Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports
    Alexander Hodkinson, Heneghan, Carl, Mahtani, Kamal R., Evangelos Kontopantelis, Maria Panagioti · 2021 · Figshare
  27. Additional file 4 of Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports
    Alexander Hodkinson, Heneghan, Carl, Mahtani, Kamal R., Evangelos Kontopantelis, Maria Panagioti · 2021 · Figshare
  28. Additional file 7 of Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports
    Alexander Hodkinson, Heneghan, Carl, Mahtani, Kamal R., Evangelos Kontopantelis, Maria Panagioti · 2021 · Figshare
  29. Additional file 14 of Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports
    Alexander Hodkinson, Heneghan, Carl, Mahtani, Kamal R., Evangelos Kontopantelis, Maria Panagioti · 2021 · Figshare
  30. Additional file 1 of Measuring the impact of zero-cases studies in evidence synthesis practice using the harms index and benefits index (Hi-Bi)
    Xu, Chang, Luis Furuya‐Kanamori, Lin, Lifeng, Liliane Zorzela, Tianqi Yu, Vohra, Sunita · 2024 · Figshare
  31. Additional file 13 of Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports
    Alexander Hodkinson, Heneghan, Carl, Mahtani, Kamal R., Evangelos Kontopantelis, Maria Panagioti · 2021 · Figshare
  32. Additional file 10 of Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports
    Alexander Hodkinson, Heneghan, Carl, Mahtani, Kamal R., Evangelos Kontopantelis, Maria Panagioti · 2021 · Figshare
  33. Additional file 15 of Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports
    Alexander Hodkinson, Heneghan, Carl, Mahtani, Kamal R., Evangelos Kontopantelis, Maria Panagioti · 2021 · Figshare
  34. Additional file 5 of Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports
    Alexander Hodkinson, Heneghan, Carl, Mahtani, Kamal R., Evangelos Kontopantelis, Maria Panagioti · 2021 · Figshare
  35. Additional file 6 of Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports
    Alexander Hodkinson, Heneghan, Carl, Mahtani, Kamal R., Evangelos Kontopantelis, Maria Panagioti · 2021 · Figshare
  36. Additional file 8 of Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports
    Alexander Hodkinson, Heneghan, Carl, Mahtani, Kamal R., Evangelos Kontopantelis, Maria Panagioti · 2021 · Figshare
  37. Additional file 9 of Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports
    Alexander Hodkinson, Heneghan, Carl, Mahtani, Kamal R., Evangelos Kontopantelis, Maria Panagioti · 2021 · Figshare
  38. Additional file 12 of Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports
    Alexander Hodkinson, Heneghan, Carl, Mahtani, Kamal R., Evangelos Kontopantelis, Maria Panagioti · 2021 · Figshare
  39. Additional file 3 of Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports
    Alexander Hodkinson, Heneghan, Carl, Mahtani, Kamal R., Evangelos Kontopantelis, Maria Panagioti · 2021 · Figshare
  40. Additional file 2 of Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports
    Alexander Hodkinson, Heneghan, Carl, Mahtani, Kamal R., Evangelos Kontopantelis, Maria Panagioti · 2021 · Figshare
  41. Additional file 11 of Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports
    Alexander Hodkinson, Heneghan, Carl, Mahtani, Kamal R., Evangelos Kontopantelis, Maria Panagioti · 2021 · Figshare